ATE159948T1 - Spicamycinderivate und deren verwendung - Google Patents

Spicamycinderivate und deren verwendung

Info

Publication number
ATE159948T1
ATE159948T1 AT92111782T AT92111782T ATE159948T1 AT E159948 T1 ATE159948 T1 AT E159948T1 AT 92111782 T AT92111782 T AT 92111782T AT 92111782 T AT92111782 T AT 92111782T AT E159948 T1 ATE159948 T1 AT E159948T1
Authority
AT
Austria
Prior art keywords
chem
denotes
integer
carbon atoms
given number
Prior art date
Application number
AT92111782T
Other languages
English (en)
Inventor
Noboru Otake
Hiroyuki Kawai
Tomiko Kawasaki
Atsuo Odagawa
Masaru Kamishohara
Teruyuki Sakai
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Application granted granted Critical
Publication of ATE159948T1 publication Critical patent/ATE159948T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT92111782T 1991-07-12 1992-07-10 Spicamycinderivate und deren verwendung ATE159948T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19890391 1991-07-12
JP32684591 1991-11-15
JP4110665A JP2783722B2 (ja) 1991-07-12 1992-04-03 スピカマイシン誘導体およびそれを含む抗腫瘍剤

Publications (1)

Publication Number Publication Date
ATE159948T1 true ATE159948T1 (de) 1997-11-15

Family

ID=27311786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92111782T ATE159948T1 (de) 1991-07-12 1992-07-10 Spicamycinderivate und deren verwendung

Country Status (16)

Country Link
US (2) US5461036A (de)
EP (1) EP0525479B1 (de)
JP (1) JP2783722B2 (de)
KR (1) KR100253050B1 (de)
AT (1) ATE159948T1 (de)
AU (1) AU657551B2 (de)
CA (1) CA2073567C (de)
DE (1) DE69222992T2 (de)
DK (1) DK0525479T3 (de)
ES (1) ES2111019T3 (de)
FI (1) FI105815B (de)
GR (1) GR3025293T3 (de)
HK (1) HK1001729A1 (de)
HU (1) HU221808B1 (de)
NO (1) NO178500C (de)
SG (1) SG52704A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7017208B2 (en) * 1995-08-04 2006-03-28 Hill-Rom Services, Inc. Hospital bed
US5905069A (en) * 1998-01-26 1999-05-18 The General Hospital Corporation Methods of decreasing or preventing pain using spicamycin or derivatives thereof
PL206627B1 (pl) * 1999-01-22 2010-09-30 Kirin Pharma Kk Pochodna chinazoliny, jej zastosowanie i kompozycja farmaceutyczna
ES2365473T3 (es) * 2000-09-20 2011-10-06 The General Hospital Corporation Procedimientos para reducir o prevenir el dolor usando derivados de espicamicina.
DK1565201T3 (en) * 2002-11-18 2019-02-25 Vicuron Pharmaceuticals Llc METHODS OF ADMINISTRATING DALBAVANCIN TO TREAT Bacterial Infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7737294B2 (en) * 2003-09-11 2010-06-15 Invista North America S.A R.L. Process of hydrocyanation of unsaturated carboxylic acid derivatives
JP4608651B2 (ja) * 2004-06-24 2011-01-12 財団法人ヒューマンサイエンス振興財団 抗ガン作用を有する化合物、その製造方法及び抗ガン剤
US8119829B2 (en) * 2004-09-08 2012-02-21 Invista North America S.A.R.L. Process of hydrocyanation of unsaturated carboxylic acid derivatives
EP2349285B1 (de) * 2008-10-10 2016-03-23 Dara Biosciences, Inc. Spicamycin-Derivat Enthaltend Nanoemulsionen zur Verwendundung in der Behandlung von Schmerzen
EP2597082A1 (de) 2011-11-24 2013-05-29 Symrise AG Verbindungen zur Maskierung eines unangenehmen Geschmacks
CA2880853A1 (en) 2012-08-09 2014-02-13 Dara Biosciences, Inc. Compositions comprising spicamycin derivatives and methods of use thereof
WO2015061481A1 (en) 2013-10-23 2015-04-30 Dara Biosciences, Inc. Methods of treating liquid tumors using compositions comprising spicamycin derivatives
CN110386874B (zh) * 2018-04-16 2022-10-04 湖北金鹤化工有限公司 一种12-酮基硬脂酸酯及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3264195A (en) * 1963-07-24 1966-08-02 Squibb & Sons Inc Process for the preparation of septacidin and derivatives
US3155647A (en) 1963-07-24 1964-11-03 Olin Mathieson Septaciding and derivatives thereof
US4086416A (en) * 1977-05-17 1978-04-25 Stanford Research Institute Septacidin analogs
JPS59161389A (ja) * 1983-03-07 1984-09-12 Eisai Co Ltd ７−カルボキシメトキシフエニルアセトアミドセフエム誘導体，その製造法およびそれからなる抗菌剤
JPS59161396A (ja) * 1983-03-04 1984-09-12 Kirin Brewery Co Ltd 新規抗生物質スピカマイシン
US4975434A (en) * 1986-05-27 1990-12-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antiviral and anticancer cyclopentenyl cytosine
WO1990015811A1 (en) 1989-06-16 1990-12-27 Kirin Beer Kabushiki Kaisha Spicamycin x and its use

Also Published As

Publication number Publication date
DK0525479T3 (da) 1998-04-20
NO178500B (no) 1996-01-02
FI105815B (fi) 2000-10-13
HU221808B1 (hu) 2003-01-28
KR100253050B1 (ko) 2000-04-15
EP0525479B1 (de) 1997-11-05
AU657551B2 (en) 1995-03-16
SG52704A1 (en) 1998-09-28
US5461036A (en) 1995-10-24
DE69222992D1 (de) 1997-12-11
FI923170A0 (fi) 1992-07-09
NO178500C (no) 1996-04-10
HU9202285D0 (en) 1992-10-28
NO922674L (no) 1993-01-13
KR930002370A (ko) 1993-02-23
GR3025293T3 (en) 1998-02-27
CA2073567A1 (en) 1993-01-13
JP2783722B2 (ja) 1998-08-06
ES2111019T3 (es) 1998-03-01
HUT61773A (en) 1993-03-01
JPH05186494A (ja) 1993-07-27
CA2073567C (en) 1998-05-05
EP0525479A1 (de) 1993-02-03
FI923170A (fi) 1993-01-13
NO922674D0 (no) 1992-07-08
HK1001729A1 (en) 1998-07-03
US5631238A (en) 1997-05-20
AU1960092A (en) 1993-01-14
DE69222992T2 (de) 1998-03-05

Similar Documents

Publication Publication Date Title
ATE176237T1 (de) Sphingoglycolipid und verwendung davon
ATE159948T1 (de) Spicamycinderivate und deren verwendung
KR950702431A (ko) 신규한 의약 조성물(novel pharmaceutical compositions)
DE3875346D1 (de) Zusammensetzungen, die mit 1-oxo- oder thiokohlenwassserstoff substituierte azacycloalkane enthalten.
DK0568147T3 (da) Polysiloxanstabilisatorer indeholdende sterisk hindrede phenolgrupper og oxamidgrupper
DE69203551T2 (de) Biologisch abbaubarer Copolyester von 4-Hydroxyprolin und diesen enthaltende pharmazeutische Zusammensetzung.
GR3034023T3 (en) Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them.
ATE178059T1 (de) 4-phenylcarbamoyl-3-isoxazolecarbonsäure-deriva e mit entzündungshemmender aktivität
DE59007487D1 (de) Hydroxyalkancarbonsäure-derivate und deren verwendung.
DE69307310D1 (de) Neue quaternäre ammoniumsalze und deren medizinische verwendung
DK606286D0 (da) Anthracyclin-derivater og laegemidler indeholdende disse forbindelser
DE69018552D1 (de) Mesomorphe Verbindung, dieselbe enthaltende flüssigkristalline Zusammensetzung und dieselbe benutzende flüssigkristalline Vorrichtung.
ATE33983T1 (de) N-substituierte tetrahydrothiazine, verfahren zu deren herstellung und deren verwendung als pestizide.
ATE24887T1 (de) Cycloaliphatische alkohole.
ES2068685T3 (es) Procedimiento de preparacion de nuevos derivados de 1,5-diin-cicloalquenos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner